04:54 PM EDT, 10/10/2025 (MT Newswires) -- Zoetis ( ZTS ) said its Lenivia treatment for dogs with osteoarthritis pain received a positive opinion recommending marketing authorization from the European Medicines Agency's Committee for Veterinary Medicinal Products.

A final decision from the European Commission is expected in Q4, with commercial availability anticipated in 2026, Zoetis ( ZTS ) said Friday in a statement.